Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Novo Nordisk B

Novo Nordisk B

Novo Nordisk B

2026 Q1 -tulosraportti
39 päivää sitten
7,95 DKK/osake
Viimeisin osinko
4,07%Tuotto/v

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
28--
12--
1 500--
1 710--
400--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
5.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
6.5.
Vuosittainen yhtiökokous 2026
26.3.
2025 Q4 -tulosraportti
4.2.
Ylimääräinen yhtiökokous 2025
14.11.2025
2025 Q3 -tulosraportti
5.11.2025

Foorumi

Liity keskusteluun Nordnet Socialissa
  • Alle minuutti sitten
    Alle minuutti sitten
    Israel gør virkelig alt for at smadre aftalen mellem Iran og USA, og trump gør intet andet end råbe og skrige som et barn. Når den aftale går i vasken også (grundet Israel), så vil markedet igen reagere og trække kapitalen tilbage var risiko og over i defensiv igen, som vi så i starten af ugen da uroen steg betydeligt.
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    When the orange man first realizes that Novo completely crushes Lly, so he sells his Lly shares and moves them into Novo, so he can manipulate it up, then it will go REALLY fast.
    22 t sitten
    ·
    22 t sitten
    ·
    Do you think you overestimate how much consideration trump has for his LLY shares, when they constitute such an insignificantly small proportion of his portfolio?
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Why are so many people so heavily invested in individual stocks, and in a seemingly impatient, hopeful, gambler-like way? I believe there is much truth in what Buffet once said when he was asked why nobody does as he does: Nobody wants go get rich slowly. As I see it, individual stocks are largely gambling. With very few exceptions (perhaps if one is an insider) it is almost impossible to know what is a value trap. Nearly impossible to come up with a correct assessment of a company's valuation and future prospects. At least nearly impossible to consistently make above-average smart analyses of that kind. I myself have been such a clown almost my entire life. I have been a terrible investor except for maybe the last few years. Regardless, as I see it, it is largely best to have broad index funds. Perhaps it's strange why I'm writing this here on the Novo-thread. This is because Novo is currently my only individual stock (as a rule, I haven't had any individual stocks; Novo constitutes 7% of the portfolio, bought a few months ago, partly bought because my wife likes healthcare and I think healthcare-ETF seems a bit expensive at the moment). The worst thing about owning Novo is the blue dots on the Nordnet-app. Endlessw notifications about the, to put it mildly, uninteresting posts written about the stock. But they become fewer along the way, I think I have muted approx. 30 Novo-"investors" in the last few days after discovering that one can clean up that way. Much needed.
    23 t sitten
    ·
    23 t sitten
    ·
    Buffet does nothing but trade individual stocks. It seems there are many things you haven't really understood.
    1 min sitten
    ·
    1 min sitten
    ·
    I perform many times better than a comparable index, but I am also not the typical private investor, who in no way spends the hours I do following the market, plus I have a quite relevant background. Not everyone fits into the usual boxes, but generally there are many who shouldn't dabble with individual stocks, or at least to a lesser extent. When you specifically mention SP500, then we could also just say what makes SP500 rise: AI. Then one might as well just invest in a group of AI stocks. But when we then talk about these AI stocks, then I believe few private individuals can reasonably relate to the current valuation, and the risk they run.
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    The Wegovy pill is currently winning the pill market. SNAC technology protects the liver and avoids interactions with other medicines. Foundayo is the 'liver-killer' pill — people avoid it because no one wants to risk losing their liver. It is very likely that the approval process in Europe for Foundayo will be extended or require additional documentation. The reason is that the US health authorities (FDA) have flagged "unexpected" signals regarding liver toxicity and require the manufacturer Eli Lilly to monitor and submit additional safety data from clinical studies. Novo has the most effective pill with the fewest side effects. People don't want to inject themselves like junkies. Everyone wants a pill, and the company with the most effective pill wins the obesity market.
    6 t sitten
    ·
    6 t sitten
    ·
    Completely agree .
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Many Danes have probably now understood why mark-to-market taxation is called "the tax from hell". Those Danes who have opened an investment savings account and invested in Novo, have paid 17% mark-to-market tax on an unrealized capital gain that has disappeared, and if they close their investment savings account, they will realize a capital loss that is lost for tax purposes.
    20 t sitten
    ·
    20 t sitten
    ·
    Ask to swing trade on, is an advantage compared to the tax %
    20 t sitten
    ·
    20 t sitten
    ·
    I swing-traded a handful of individual stocks on ASK until it went over 250k and then switched to a handful of investment fund units.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q1 -tulosraportti
39 päivää sitten
7,95 DKK/osake
Viimeisin osinko
4,07%Tuotto/v

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Foorumi

Liity keskusteluun Nordnet Socialissa
  • Alle minuutti sitten
    Alle minuutti sitten
    Israel gør virkelig alt for at smadre aftalen mellem Iran og USA, og trump gør intet andet end råbe og skrige som et barn. Når den aftale går i vasken også (grundet Israel), så vil markedet igen reagere og trække kapitalen tilbage var risiko og over i defensiv igen, som vi så i starten af ugen da uroen steg betydeligt.
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    When the orange man first realizes that Novo completely crushes Lly, so he sells his Lly shares and moves them into Novo, so he can manipulate it up, then it will go REALLY fast.
    22 t sitten
    ·
    22 t sitten
    ·
    Do you think you overestimate how much consideration trump has for his LLY shares, when they constitute such an insignificantly small proportion of his portfolio?
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Why are so many people so heavily invested in individual stocks, and in a seemingly impatient, hopeful, gambler-like way? I believe there is much truth in what Buffet once said when he was asked why nobody does as he does: Nobody wants go get rich slowly. As I see it, individual stocks are largely gambling. With very few exceptions (perhaps if one is an insider) it is almost impossible to know what is a value trap. Nearly impossible to come up with a correct assessment of a company's valuation and future prospects. At least nearly impossible to consistently make above-average smart analyses of that kind. I myself have been such a clown almost my entire life. I have been a terrible investor except for maybe the last few years. Regardless, as I see it, it is largely best to have broad index funds. Perhaps it's strange why I'm writing this here on the Novo-thread. This is because Novo is currently my only individual stock (as a rule, I haven't had any individual stocks; Novo constitutes 7% of the portfolio, bought a few months ago, partly bought because my wife likes healthcare and I think healthcare-ETF seems a bit expensive at the moment). The worst thing about owning Novo is the blue dots on the Nordnet-app. Endlessw notifications about the, to put it mildly, uninteresting posts written about the stock. But they become fewer along the way, I think I have muted approx. 30 Novo-"investors" in the last few days after discovering that one can clean up that way. Much needed.
    23 t sitten
    ·
    23 t sitten
    ·
    Buffet does nothing but trade individual stocks. It seems there are many things you haven't really understood.
    1 min sitten
    ·
    1 min sitten
    ·
    I perform many times better than a comparable index, but I am also not the typical private investor, who in no way spends the hours I do following the market, plus I have a quite relevant background. Not everyone fits into the usual boxes, but generally there are many who shouldn't dabble with individual stocks, or at least to a lesser extent. When you specifically mention SP500, then we could also just say what makes SP500 rise: AI. Then one might as well just invest in a group of AI stocks. But when we then talk about these AI stocks, then I believe few private individuals can reasonably relate to the current valuation, and the risk they run.
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    The Wegovy pill is currently winning the pill market. SNAC technology protects the liver and avoids interactions with other medicines. Foundayo is the 'liver-killer' pill — people avoid it because no one wants to risk losing their liver. It is very likely that the approval process in Europe for Foundayo will be extended or require additional documentation. The reason is that the US health authorities (FDA) have flagged "unexpected" signals regarding liver toxicity and require the manufacturer Eli Lilly to monitor and submit additional safety data from clinical studies. Novo has the most effective pill with the fewest side effects. People don't want to inject themselves like junkies. Everyone wants a pill, and the company with the most effective pill wins the obesity market.
    6 t sitten
    ·
    6 t sitten
    ·
    Completely agree .
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Many Danes have probably now understood why mark-to-market taxation is called "the tax from hell". Those Danes who have opened an investment savings account and invested in Novo, have paid 17% mark-to-market tax on an unrealized capital gain that has disappeared, and if they close their investment savings account, they will realize a capital loss that is lost for tax purposes.
    20 t sitten
    ·
    20 t sitten
    ·
    Ask to swing trade on, is an advantage compared to the tax %
    20 t sitten
    ·
    20 t sitten
    ·
    I swing-traded a handful of individual stocks on ASK until it went over 250k and then switched to a handful of investment fund units.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
28--
12--
1 500--
1 710--
400--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
5.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
6.5.
Vuosittainen yhtiökokous 2026
26.3.
2025 Q4 -tulosraportti
4.2.
Ylimääräinen yhtiökokous 2025
14.11.2025
2025 Q3 -tulosraportti
5.11.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

2026 Q1 -tulosraportti
39 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q2 -tulosraportti
5.8.
Menneet tapahtumat
2026 Q1 -tulosraportti
6.5.
Vuosittainen yhtiökokous 2026
26.3.
2025 Q4 -tulosraportti
4.2.
Ylimääräinen yhtiökokous 2025
14.11.2025
2025 Q3 -tulosraportti
5.11.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

7,95 DKK/osake
Viimeisin osinko
4,07%Tuotto/v

Foorumi

Liity keskusteluun Nordnet Socialissa
  • Alle minuutti sitten
    Alle minuutti sitten
    Israel gør virkelig alt for at smadre aftalen mellem Iran og USA, og trump gør intet andet end råbe og skrige som et barn. Når den aftale går i vasken også (grundet Israel), så vil markedet igen reagere og trække kapitalen tilbage var risiko og over i defensiv igen, som vi så i starten af ugen da uroen steg betydeligt.
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    When the orange man first realizes that Novo completely crushes Lly, so he sells his Lly shares and moves them into Novo, so he can manipulate it up, then it will go REALLY fast.
    22 t sitten
    ·
    22 t sitten
    ·
    Do you think you overestimate how much consideration trump has for his LLY shares, when they constitute such an insignificantly small proportion of his portfolio?
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Why are so many people so heavily invested in individual stocks, and in a seemingly impatient, hopeful, gambler-like way? I believe there is much truth in what Buffet once said when he was asked why nobody does as he does: Nobody wants go get rich slowly. As I see it, individual stocks are largely gambling. With very few exceptions (perhaps if one is an insider) it is almost impossible to know what is a value trap. Nearly impossible to come up with a correct assessment of a company's valuation and future prospects. At least nearly impossible to consistently make above-average smart analyses of that kind. I myself have been such a clown almost my entire life. I have been a terrible investor except for maybe the last few years. Regardless, as I see it, it is largely best to have broad index funds. Perhaps it's strange why I'm writing this here on the Novo-thread. This is because Novo is currently my only individual stock (as a rule, I haven't had any individual stocks; Novo constitutes 7% of the portfolio, bought a few months ago, partly bought because my wife likes healthcare and I think healthcare-ETF seems a bit expensive at the moment). The worst thing about owning Novo is the blue dots on the Nordnet-app. Endlessw notifications about the, to put it mildly, uninteresting posts written about the stock. But they become fewer along the way, I think I have muted approx. 30 Novo-"investors" in the last few days after discovering that one can clean up that way. Much needed.
    23 t sitten
    ·
    23 t sitten
    ·
    Buffet does nothing but trade individual stocks. It seems there are many things you haven't really understood.
    1 min sitten
    ·
    1 min sitten
    ·
    I perform many times better than a comparable index, but I am also not the typical private investor, who in no way spends the hours I do following the market, plus I have a quite relevant background. Not everyone fits into the usual boxes, but generally there are many who shouldn't dabble with individual stocks, or at least to a lesser extent. When you specifically mention SP500, then we could also just say what makes SP500 rise: AI. Then one might as well just invest in a group of AI stocks. But when we then talk about these AI stocks, then I believe few private individuals can reasonably relate to the current valuation, and the risk they run.
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    The Wegovy pill is currently winning the pill market. SNAC technology protects the liver and avoids interactions with other medicines. Foundayo is the 'liver-killer' pill — people avoid it because no one wants to risk losing their liver. It is very likely that the approval process in Europe for Foundayo will be extended or require additional documentation. The reason is that the US health authorities (FDA) have flagged "unexpected" signals regarding liver toxicity and require the manufacturer Eli Lilly to monitor and submit additional safety data from clinical studies. Novo has the most effective pill with the fewest side effects. People don't want to inject themselves like junkies. Everyone wants a pill, and the company with the most effective pill wins the obesity market.
    6 t sitten
    ·
    6 t sitten
    ·
    Completely agree .
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Many Danes have probably now understood why mark-to-market taxation is called "the tax from hell". Those Danes who have opened an investment savings account and invested in Novo, have paid 17% mark-to-market tax on an unrealized capital gain that has disappeared, and if they close their investment savings account, they will realize a capital loss that is lost for tax purposes.
    20 t sitten
    ·
    20 t sitten
    ·
    Ask to swing trade on, is an advantage compared to the tax %
    20 t sitten
    ·
    20 t sitten
    ·
    I swing-traded a handful of individual stocks on ASK until it went over 250k and then switched to a handful of investment fund units.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
28--
12--
1 500--
1 710--
400--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt